Kennedy Capital Management’s DexCom DXCM Stock Holding History

Kennedy Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.69M	Sell	69,592 -3,095	-4%	-$206K	0.08%	342
2026 Q1	$4.56M	Buy	72,687 +143	+0.2%	+$9.96K	0.1%	312
2025 Q4	$4.81M	Buy	72,544 +62,077	+593%	+$4.01M	0.1%	305
2025 Q3	$704K	Sell	10,467 -8,063	-44%	-$638K	0.02%	521
2025 Q2	$1.62M	Sell	18,530 -12,440	-40%	-$975K	0.04%	467
2025 Q1	$2.11M	Buy	+30,970	New	+$2.53M	0.05%	430
2024 Q4	–	Sell	-47,528	Closed	-$3.19M	–	693
2024 Q3	$3.19M	Buy	47,528 +26,762	+129%	+$2.2M	0.07%	408
2024 Q2	$2.35M	Buy	20,766 +8,584	+70%	+$1.09M	0.05%	486
2024 Q1	$1.69M	Buy	+12,182	New	+$1.53M	0.03%	549

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kennedy Capital Management's DXCM Position: Q2 2026 in Review

Kennedy Capital Management reduced its DexCom (DXCM) stake by 4.3% in Q2 2026, selling an estimated $206K and leaving 69,592 shares worth $4.69M. The position accounts for 0.08% of the portfolio, ranked #342.

Kennedy Capital Management first reported a position in DXCM in Q1 2024 and has held it in 9 quarters since. The position peaked at $4.81M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Kennedy Capital Management held 69,592 shares of DexCom worth $4.69M as of Q2 2026.
Kennedy Capital Management sold 3,095 DexCom shares in Q2 2026, an estimated $206K.
DexCom made up 0.08% of Kennedy Capital Management's portfolio in Q2 2026, its #342 holding.
Kennedy Capital Management first reported a position in DexCom in Q1 2024 and has held it in 9 quarters since.
Kennedy Capital Management's DexCom position peaked at $4.81M in Q4 2025.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.